Presented 48-month data from the GALE extension study at The Macula Society Annual Meeting in February 2025 demonstrating that early treatment with SYFOVRE leads to preservation of retinal tissue at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results